Ev3 Goes Global
Executive Summary
While other medical device start-ups are turning away from international distribution, ev3, a new endovascular roll-up founded by a number of former SciMed executives, is preaching the value and importance of an international sales effort and are inviting other device companies to join them.
You may also be interested in...
Covidien Runs Familiar But Different Plays to Build Vascular Franchise
Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.
Covidien Runs Familiar But Different Plays to Build Vascular Franchise
Covidien Ltd. continues to build its vascular global business unit with the acquisition of peripheral leader ev3 Inc.
CVRx: Can Devices Succeed Where Drugs Fail for High Blood Pressure?
With hypertension reaching pandemic proportions, more and more people are not successfully treated with the drugs that, until now, have been the only therapy. CVRx is the first to develop a device to provide patients with another option.